Significant Ownership of Cambridge Equities, LP

Signature - Title
/s/ Charles Kenworthy - Charles Kenworthy, Manager of MP 13 Ventures, LLC, the General Partner of Cambridge Equities, LP
Location
El Segundo, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Cambridge Equities, LP.

Notify me when Cambridge Equities, LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Cambridge Equities, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
IBRX ImmunityBio, Inc. Common Stock, par value $0.0001 per share 69% $1,830,169,152 743,971,200 Patrick Soon-Shiong 10 Nov 2025

Schedules 13D/G Reported by Cambridge Equities, LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.